# SUPRANE

NDC: 10019-646
Generic name: DESFLURANE
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: LIQUID
Routes: RESPIRATORY (INHALATION)
Marketing started: 19920918

FDA application: NDA020118

## Active ingredients

- DESFLURANE: 240 mL/240mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"10019-646"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=10019-646
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f977eb6-c7c4-4dc5-ab3b-07414dbe5da5